Rumble announces exploration highlights for multiple drill targets

|

Published 05-JUN-2018 15:43 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Rumble Resources Ltd (ASX:RTR) has announced details of its exploration activities at its high grade base metal Braeside Project in Western Australia.

RTR has completed the first stage of pXRF soil sampling within E45/2032 and regional soil sampling in E45/4873. The exploration has highlighted a multitude of first order zinc (Zn) and lead (Pb) targets associated with large northwest to north trending alteration zones.

These are inferred to be feeder structures to a porphyry related mineralising system and Zn rich disseminated mineralisation in siltstone.

Here is a look at the regional geology and tenement status of the Braeside Project:

Some of the highlights include:

Five new first order targets with the potential for high grade breccia Zn pipes have been outlined. This is in addition to the new high-grade zinc discovery defined by a single RC drill hole at the Devon Cut Prospect.

The new targets have a similar or higher order Zn response and size to the high-grade Zn discovery RC drill hole geochemical parameters.

What comes of these targets remains to be seen, so investors should seek professional financial advice if considering this stock for their portfolio.

15 zones have now been delineated with 23 first order targets within E45/2032. At least two styles of base metal anomalism (representing targets) have been recognised.

The Zn and Pb mineralisation is associated with multiple highly altered silica – sericite – chlorite fracture/feeder zones over significant strike lengths. Zones in addition to Devon Cut include Mt Brockman 2 South and Boom Boom Mancini.

Widespread disseminated Zn mineralisation has been recorded in altered siltstones at Mt Brockman 2 Central Zn and Baker’s Dozen.

The RTR field crew is currently completing detailed grab sampling and prospect mapping to optimise the proposed RC drill-hole program at all 23 first order drill targets.

Braeside Project – location of pXRF soil sampling and results summary

In the last two months, RTR has been systematically exploring using surface geochemistry to delineate high order targets ready for the upcoming RC drilling program. This follows the discovery of the Devon Cut high-grade Zn mineralisation with RC drilling in November last year.

Devon Cut Prospect – pXRF Zn in soil geochemistry and targetsDevon Cut Prospect – a look at the oxidised mineralisation textures

RTR is completing systematic targeting, with detailed prospecting of the defined targets ongoing. Work underway includes extensive multi-element grab/rock chip sampling and geological reconnaissance.

Results are pending for approximately 200 grab samples taken over the high order base metal targets.

As exploration continues, numerous high priority targets are being generated. The company is optimising the best targets for the proposed RC drilling program. As a result of the many first order targets being identified, the RC drilling has been rescheduled for August 2018 to ensure RTR delineates the best targets.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X